NCT00976950 - A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions

HIV Infections

Interventions

DRUG

Tipranavir

DRUG

ritonavir

low-dose

Trial Locations (20)

Boehringer Ingelheim Investigational site 9, Arad

Boehringer Ingelheim Investigational site 13, Bacau

Boehringer Ingelheim Investigational site 17, Brasov

Boehringer Ingelheim Investigational site 18, Brasov

Boehringer Ingelheim Investigational site 19, Brasov

Boehringer Ingelheim Investigational site 1, Bucharest

Boehringer Ingelheim Investigational site 2, Bucharest

Boehringer Ingelheim Investigational site 3, Bucharest

Boehringer Ingelheim Investigational site 4, Bucharest

Boehringer Ingelheim Investigational site 5, Bucharest

Boehringer Ingelheim Investigational site 6, Bucharest

Boehringer Ingelheim Investigational site 7, Bucharest

Boehringer Ingelheim Investigational site 8, Bucharest

Boehringer Ingelheim Investigational site 16, Constanța

Boehringer Ingelheim Investigational site 11, Craiova

Boehringer Ingelheim Investigational site 12, Craiova

Boehringer Ingelheim Investigational site 15, Galati

Boehringer Ingelheim Investigational site 20, Tg.Mures

Boehringer Ingelheim Investigational site 10, Timișoara

Boehringer Ingelheim Investigational site 14, Vaslui